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Abstract
Objective We aimed to investigate the effect of dietary
intake of micronutrients that are metabolized and excreted
via the urinary tract on bladder cancer risk.
Methods A semi-quantitative 322 item food frequency
questionnaire (FFQ) was used to collect dietary data from
200 bladder cancer cases and 386 control subjects partici-
pating in the Belgian case–control study on bladder cancer
risk. Odds ratios (ORs) and 95% conﬁdence intervals (CIs)
were calculated using unconditional logistic regression
adjusting for age, sex, smoking characteristics, occupa-
tional exposures, and energy intake.
Results We observed a positive association between cal-
cium intake and bladder cancer (OR: 1.77; 95% CI:
1.00–3.15; p-trend = 0.049) and increased odds, although
not statistically signiﬁcant, for highest tertile of phosphorus
intake (OR: 1.82; 95% CI: 0.95–3.49; p-trend = 0.06).
We identiﬁed possible modiﬁcation of the effects of both
calcium and phosphorus by level of magnesium intake.
Increased odds of bladder cancer were also observed for
participants with highest intake of phosphorus and lowest
intake of vitamin D (OR: 4.25; 95% CI: 1.44–12.55) and
among older participants with the highest intakes of cal-
cium (OR: 1.90; 95% CI: 1.08–3.36) and phosphorus (OR:
2.02; 95% CI: 1.05–3.92).
Conclusion The positive associations we observed between
bladder cancer and intake of calcium and phosphorus require
conﬁrmation by other studies. The balances between inter-
related micronutrients also warrant further examination.
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Bladder cancer is a major health problem particularly for
aging males from Western populations [1]. Many dietary
components are metabolized and excreted in the urinary
tract increasing the biologically plausibility that certain
minerals and vitamins or their metabolites have the
potential to either inhibit or promote bladder carcinogen-
esis [2].
A systematic review [3] reported that the essential trace
mineral, selenium may have a protective effect against
developing bladder cancer. Less information, however, is
available on the effect of other dietary micronutrients that
are present in daily urine excretion. These include elec-
trolytes, sodium and potassium and major dietary minerals
such as calcium, magnesium, and phosphorus [4].
Sodium is an essential mineral that in high doses has
been shown to promote bladder carcinogenesis in rodents
[4]. An all-male case–control study conducted in the US [5]
consisting of 351 cases and 855 controls, also reported a
positive association between sodium intake and bladder
cancer incidence. Two other US studies, however, a pro-
spective cohort study of male health professionals [6] and a
case–control study [7] observed no association between
sodium intake and bladder cancer. These two epidemio-
logical studies [6, 7] also failed to detect an association
with potassium. This major intracellular mineral has sim-
ilar functions to sodium, although quite often in the
opposite direction and according to animal studies may be
involved in cellular proliferation [4, 8].
Depending on their chemical form, calcium and mag-
nesium may increase the risk of bladder cancer through the
development of precipitates/calculi, inﬂuence on urine pH
and interaction with other urine components [4]. To date,
however, few epidemiological studies [5–7, 9, 10] have
actually examined the effect of these minerals on bladder
cancer risk. Whereas a multi-centre Spanish case–control
study [9] observed a positive association with bladder
cancer, although this disappeared after adjusting for satu-
rated fat intake, three US studies [5–7] and one Dutch
prospective cohort study [10] reported no association with
calcium intake. Inverse associations have been reported
between magnesium intake and cancers at several other
body sites, e.g., the colon [11], liver [12], and esophagus
[13] but only two US studies [6, 7] have investigated its
relationship with bladder cancer. While the case–control
study [7] observed no association, the prospective study [6]
reported an inverse association between magnesium and
bladder cancer prior to multivariate analysis.
Phosphorus has a number of key physiological functions
including its roles in bone mineralization and as an
important component of nucleic acids and cellular mem-
brane [14]. This mineral also biologically interacts with
calcium and vitamin D [15]. To our knowledge, only two
epidemiological studies [6, 7] have investigated the effect
of phosphorus intake in relation to bladder cancer.
Following adjustment for several potential confounders,
the inverse association with bladder cancer disappeared in
the prospective study [6] and was borderline statistically
signiﬁcant (dietary phosphorus only) in the case–control
study [7].
Deﬁciencies in some minerals and vitamins such as iron,
zinc, and B group vitamins are reported to possibly
increase the risk of cancer by causing damage to DNA
similar to radiation exposure [16]. Although the mecha-
nism by which copper deﬁciency possibly inﬂuences car-
cinogenesis has not been elucidated [4], it may be due to its
role in the superoxide dismutase (SOD) enzymes, which
help to prevent oxidative damage to the cell membranes
[8]. However, the effect of dietary intake of copper on the
risk of developing bladder cancer has not been investigated
previously, and only few epidemiological studies have
examined potential associations with dietary iron [6, 7, 9],
zinc [17, 18] and vitamins B1 (thiamin) and B2 (riboﬂavin)
[5–7, 19].
While the epidemiological evidence for any associations
between micronutrients included in this study and bladder
cancer is sparse and inconsistent, it is virtually non-existent
for the combined effects of major inter-related micronu-
trients. Calcium, magnesium, phosphorus, and vitamin D
not only share common food sources but are ‘‘metaboli-
cally interactive’’ as well [4]. Examining the effect of a
single micronutrient without taking into account the inﬂu-
ence of complementary or opposing nutrients may lead to
residual confounding and incomplete risk assessment.
Therefore, the aim of our study was to evaluate the effect
of dietary intake of minerals and vitamins that have a
biological association with bladder cancer risk, in terms of
both main and potential interaction effects.
Methods
Study population
The design of the Belgian case–control study on bladder
cancer risk has been described previously in detail [20].
Brieﬂy, our study was a population-based case–control
study conducted in the Belgian province of Limburg con-
sisting of 200 bladder cancer cases and 386 healthy control
subjects [20]. All cases included in the study were incident
cases identiﬁed with histologically conﬁrmed transitional
cell carcinoma (TCC) of the bladder between 1999 and
2004. Cases were derived from the Limburg Cancer Reg-
istry (LIKAR) and invited to participate in the study by
urologists and general practitioners. Since strict Belgian
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123privacy laws preclude direct access to population registers,
control subjects were selected through the Belgian
authority, Kruispuntbank van de Sociale Zekerheid
(Crossroads Bank of Social Security). This was done via
simple random sampling, stratiﬁed by municipality and
social economic status among inhabitants from the prov-
ince of Limburg who were 50 years of age and older,
without a diagnosis of transitional cell carcinoma of the
bladder. The selected individuals were invited by mail to
participate in the study. The study was approved by the
Ethical Review Board of the Medical School of the Kath-
olieke Universiteit of Leuven, and all participants provided
written informed consent [20].
Data collection
The IMMIDIET standardized food frequency questionnaire
(FFQ) was sent by mail to all participants in the study. The
IMMIDIET FFQ was developed previously for another
study, ‘‘Dietary Habits Proﬁle in European Communities
with Different Risk of Myocardial Infarction: the Impact of
Migration as a Model of Gene/Environment Interaction’’
(The IMMIDIET Project which was funded by the Euro-
pean Union in the 5th Framework Programme under Key
Action 1: Food, Nutrition and Health, QLK1-CT-2000-
00100) [21]. The IMMIDIET FFQ has been validated [22,
23] and focuses speciﬁcally on the Belgian population [21].
The semi-quantitative FFQ contains 322 food items and is
linked to the combined contents of three existing food
tables (the NEVO table for the Netherlands [24], the Bel-
gian Nubel table [25], and the IPL table [26] for Franco-
phone Belgians) supplemented with information on the
composition of common recipes from the region. Partici-
pants were asked to report their usual dietary intake for the
12 months prior to the interview. Three trained inter-
viewers visited cases and controls at home and also
obtained information via a structured interview on partic-
ipants’ medical history, lifetime smoking history (never,
ex-smoker, current smoker), family history of bladder
cancer, 20 year residential and lifetime occupational
history [20].
Exposure assessment
The FFQ was based on a ﬁxed response format consisting
of nine categories for frequency of food consumption
(never/seldom, 1–3 day/month, 1, 2, 3, 4, 5, 6, 7 days/
week) and ten questions relating to food supplement intake
(including vitamin A, vitamin C, vitamin D, vitamin E,
multivitamins, other vitamins (open-ended question), iron,
calcium, protein supplements, and an open-ended question
to list other supplements). For some food items, alternative
response options were provided, distinguishing between
ﬁve frequency categories ((almost) never, sometimes, 50%
of the time, most of the time, (almost) always). Intake
quantity was assessed based on standard household mea-
sures (5 categories: 1, 2, 3, 4, C5 table spoons/glasses/
slices/portions, etc. or, alternatively, 1–2, 3–4, 5–6, 7–8,
C9 tablespoons, etc.) and an open-ended response option
(number of grams/pieces/plates, etc.). Each FFQ was
electronically scanned and linked by an adapted version of
the Nutritional Analysis of FFQ (NAF) computer software
program developed by Instituto Nazionale Tumori
(Epidemiology Unit) in Milan to the combined food com-
position table. This allowed for the conversion of house-
hold units into grams/micrograms etc. and the calculation
of average daily intakes of food/groups and 29 nutrients.
Statistical analysis
Mineral and vitamin intake from both food sources and
food supplements was calculated. Minerals included
sodium, potassium, magnesium, phosphorus, copper, zinc,
and iron. These and vitamins thiamin (B1) and riboﬂavin
(B2) were all measured in milligrams (mg). The only other
micronutrient, Vitamin D, was measured in micrograms
(lg). To enable analysis based on tertiles, cut-off points
were determined according to distributions among controls.
The effect of these minerals and vitamins on the risk of
bladder cancer was estimated by calculating odds ratios
(ORs) and 95% conﬁdence intervals (CIs) using uncondi-
tional logistic regression. We compared the odds for tertile
intake categories between cases and controls, with the
lowest tertile of intake as the reference category. Adjust-
ment was made for the following potential confounders:
age, sex, smoking characteristics (status, number of
cigarettes smoked per day and the number of years of
smoking cigarettes), occupational exposure (for longest
occupation performed)to polycyclic aromatic hydrocarbons
(PAHs) and aromatic amines (never vs. ever), and energy
intake (kcal/day). Analyses were repeated to account for
other factors as well, including alcohol, water, coffee, and
tea consumption, which might modulate the action of
minerals and water-soluble vitamins. However, this exten-
ded adjustment did not appreciably change the results.
Likelihood ratio tests were conducted to test for trend by
assigning an integer value to each tertile of nutrient intake,
e.g., 1–3, followed by entering the term as a continuous
variable in the model. Additional analyses were performed
to investigate the joint effects of micronutrients known for
their biological interaction as well as the joint effects of
minerals and established risk factors for bladder cancer:
age, sex, and smoking characteristics (status, number of
cigarettes smoked per day and number of years of smoking
cigarettes). For this purpose, micronutrient intake level,
age, cigarettes per day, and duration of smoking cigarettes
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123were cut into two categories based on either tertile scores
(minerals; highest plus middle vs. lowest tertile) or median
values (other variables; high vs. low) obtained from con-
trols. Smoking status was dichotomized into current/non-
current smoker, age into younger or older than 62 years,
cigarettes smoked per day into less or more than 15 ciga-
rettes per day, and duration of smoking into less than or
more than 10 years of cigarette smoking. Study subjects
were stratiﬁed into four categories according to intake level
for each pair of minerals (high–high, high–low, low–high,
and low–low). Subsequently, ORs were calculated com-
paring the odds for each category between cases and con-
trols, with the low–low category as the reference category
and using logistic regression analysis to adjust for potential
confounding by age, gender, smoking characteristics,
occupational exposure, and energy intake. Interaction
between micronutrients (highest versus lowest intakes) and
age, sex and smoking characteristics was tested by com-
paring the log likelihood of regression models with and
without the relevant interaction term. We estimated the
false-positive report probability (FPRP), expressing the
probability of a spurious association between nutrient
intake and bladder cancer risk, even in the case of a sta-
tistically signiﬁcant ﬁnding. This procedure takes into
account three factors that may inﬂuence the probability of a
false-positive ﬁnding: (1) prior probability of a true asso-
ciation, (2) alpha level, and (3) statistical power to detect
an odds ratio for the alternative hypothesis at a given
p value or alpha level [27]. We used previously reported
arbitrary values for this test: 0.25 (prior probability for an
OR of 1.5), 0.5 (upper limit of noteworthiness), and 0.05
(alpha level) [27, 28]. Additionally, observed P values
were calibrated and used to transform a preselected prior
probability of a true association (10%) to the lower bound
of the posterior probability of no association (null
hypothesis) [29]. The Stata 10 statistical software program
[30] was used for all analyses except for calibration of
p values (Excel). Two-tailed p values\0.05 were con-
sidered to reﬂect statistical signiﬁcance.
Results
A total of 586 participants (200 cases and 386 controls)
were included in the study. Data from 11 participants
(2casesand9controls)reportingextremeenergyintake,that
is\1st or[99th percentiles were excluded from analyses.
Therefore, dietary data from a total of 198 cases and 377
controls were included in the analyses of this study.
Table 1 presents the study characteristics of the partic-
ipants in the Belgian case–control study on bladder cancer.
There were a greater percentage of males in both groups,
and this percentage was higher in cases than controls
(86 and 60%, respectively). On average, cases were older
than controls (p\0.001). Furthermore, cases were more
often current smokers, smoked more cigarettes per day, and
had smoked for a longer period than controls. There were
no statistically signiﬁcant differences between cases and
controls for the average daily intake of the micronutrients
under investigation (Table 1). Similarly, exposure to
occupational carcinogens and intake of major dietary fac-
tors: energy (kcal), fat, water, alcohol, and tea and coffee
were not statistically signiﬁcantly different between cases
and controls (data not shown).
The ORs and 95% CIs for dietary intake of minerals and
vitamins and bladder cancer are presented in Table 2.A
positive association was observed between intake of
Table 1 Study characteristics of participants in the Belgian case–
control study on bladder cancer
Cases n (%) Controls n (%) p-Values
Sex \0.001
Women 27 [14] 151 [40]
Men 171 (86) 226 (60)
Age \0.001
Mean (SD) 67.6 (9.9) 64.2 (9.6)
Smoking status \0.001
Non-current 32 (16) 156 (41)
Current 166 (84) 221 (59)
Smoking duration \0.001
\10 years 33 (17) 182 (48)
[10 years 165 (83) 194 (52)
Cigarettes/day \0.001
\15/day 86 (43) 259 (69)
>15/day 112 (57) 117 (31)
Occupational exposure
a 0.11
No 169 (85) 338 (90)
Yes 29 [15] 38 [10]
Micronutrient
Intake
Cases
mean (SD)
Controls
mean (SD)
p-values
Sodium (mg) 4,096.08 (2269.37) 4,600.64 (4706.48) 0.08
Potassium (mg) 4,991.91 (1766.33) 5,296.59 (2565.05) 0.10
Calcium (mg) 1,127.16 (570.99) 1,194.46 (840.17) 0.26
Magnesium (mg) 436.46 (165.29) 461.99 (227.31) 0.12
Phosphorus (mg) 1,898.29 (769.42) 1,940.38 (841.74) 0.56
Zinc (mg) 14.47 (6.35) 14.73 (7.45) 0.66
Copper (mg) 2.53 (1.72) 2.78 (2.00) 0.12
Iron (mg) 21.28 (8.76) 23.11 (18.11) 0.10
Vitamin D (lg) 7.24 (17.92) 8.54 (18.22) 0.41
Thiamin (mg) 1.67 (0.77) 1.77 (0.91) 0.17
Riboﬂavin (mg) 1.92 (0.78) 2.03 (1.01) 0.15
n number, SD standard deviation, mg milligrams, lg micrograms
a Occupation exposure never vs. ever PAHs and aromatic amines
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123calcium and bladder cancer (OR: 1.77; 95% CI: 1.00–3.15;
p-trend = 0.049). Although there was an increased asso-
ciation of bladder cancer with a higher consumption of
phosphorus, this was not statistically signiﬁcant (OR: 1.82;
95% CI: 0.95–3.49; p-trend = 0.06). No associations were
observed between any of the other minerals or vitamins and
the risk of bladder cancer. These included: sodium,
potassium, magnesium, copper, zinc, iron, vitamin D, thi-
amin, and riboﬂavin.
As higher odds of bladder cancer were observed for both
calcium and phosphorus additional analyses were con-
ducted to examine the joint effects of these minerals
together and with other key metabolically interacting
micronutrients, magnesium and vitamin D. Table 3 shows
the ORs and 95% CIs for all four inter-related micronu-
trients and bladder cancer. Participants who had the lowest
intake of magnesium and were in the highest category for
both calcium and phosphorus intake had a statistically
signiﬁcantly higher odds of bladder cancer (OR: 3.45; 95%
CI: 1.48–8.04; OR: 3.91; 95% CI: 1.45–10.49, respec-
tively). Levels of vitamin D had no effect on the associa-
tion between calcium and bladder cancer, whereas lower
levels of vitamin D in combination with a higher intake of
phosphorus did signiﬁcantly increase the odds of bladder
Table 2 Adjusted odds ratios
(OR) and 95% conﬁdence
intervals (CI) for tertile
categories of mineral and
vitamin intake and bladder
cancer status
Adjusted for age, sex, smoking
status, number of cigarettes
smoked per day, number of
years of cigarette smoking and
exposure to occupational
carcinogens (exposure to PAHs
and aromatic amines) and
energy intake (kcal/day)
Tertile of daily intake 1st (lowest) 2nd 3rd (highest) p-trend
Sodium (mg/day) 1313.7–3164.5 3164.6–4248.2 C4248.3
Case/control 64/125 70/126 62/125
OR (95% CI) 1.0 (reference) 1.36 (0.82–2.24) 1.37 (0.74–2.55) 0.29
Potassium (mg/day) 1872.3–4218.2 4218.3–5533.5 C5533.6
Case/control 70/124 64/127 62/125
OR (95 CI) 1.0 (reference) 0.80 (0.49–1.31) 1.02 (0.57–1.85) 0.99
Calcium (mg/day) 349.9–873.5 873.6–1252.1 C1252.2
Case/Control 65/125 71/127 59/125
OR (95 CI) 1.0 (reference) 1.32 (0.81–2.15) 1.77 (1.00–3.15) 0.049
Magnesium (mg/day) 125.3–370.4 370.5–482.5 C482.6
Case/control 74/125 63/127 60/125
OR (95 CI) 1.0 (reference) 0.99 (0.60–1.63) 1.00 (0.54–1.83) 0.99
Phosphorus (mg/day) 799.8–1542.9 1543.0–2087.1 C2087.2
Case/control 57/125 72/126 65/125
OR (95 CI) 1.0 (reference) 1.73 (1.03–2.92) 1.82 (0.95–3.49) 0.06
Zinc (mg/day) 4.7–11.1 11.2–15.5 C15.6
Case/control 61/125 69/125 68/126
OR (95 CI) 1.0 (reference) 1.53 (0.91–2.55) 1.55 (0.83–2.91) 0.16
Copper (mg/day) 0.6–1.8 1.9–2.7 C2.8
Case/control 84/125 61/125 52/126
OR (95 CI) 1.0 (reference) 0.81 (0.50–1.32) 0.68 (0.38–1.21) 0.19
Iron (mg/day) 6.5–16.9 17.0–22.7 C22.8
Case/control 60/125 60/126 77/126
OR (95 CI)* 1.0 (reference) 1.01 (0.60–1.69) 1.64 (0.89–3.01) 0.11
Vitamin D (lg/day) 0.2–2.0 2.1–3.7 C3.8
Case/control 68/125 58/125 72/126
OR (95 CI) 1.0 (reference) 0.76 (0.47–1.24) 1.03 (0.62–1.72) 0.93
Thiamin (mg/day)
B1
0.7–1.3 1.4–1.7 C1.8
Case/control 63/124 71/127 58/125
OR (95 CI) 1.0 (reference) 1.18 (0.71–1.94) 1.07 (0.58–1.99) 0.79
Riboﬂavin (mg/day)
B2
0.7–1.5 1.6–2.1 C2.2
Case/control 66/125 73/127 57/125
OR (95 CI) 1.0 (reference) 1.56 (0.95–2.56) 1.35 (0.73–2.49) 0.28
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123cancer (OR: 4.25; 95% CI: 1.44–12.55). A similar effect
was observed for a higher intake of phosphorus combined
with a lower intake of calcium (OR: 3.02; 95% CI:
1.01–9.02), and higher phosphorus combined with higher
magnesium intake (OR: 3.26: 95% CI: 1.10–9.65). It
should be noted, however, that none of the p values for
interaction between any of the inter-related micronutrients
were statistically signiﬁcant (data not shown).
We performed FPRP calculations to further examine the
probability of the statistically signiﬁcant associations
observed between bladder cancer and calcium intake
overall and for the combinations of minerals and vitamins
indicated in Table 3. Assuming a 25% prior probability of
a true association (OR = 1.5) and applying the noteworthy
level of 0.5 previously reported in other epidemiological
studies [28, 31], we found noteworthy results for high
calcium intake (false-discovery probability = 0.35), for the
increased odds of bladder cancer resulting from low mag-
nesium and corresponding high intakes of both calcium
(false-discovery probability = 0.32) and phosphorus
(false-discovery probability = 0.42) and high phosphorus
with low vitamin D intake (false-discovery probabil-
ity = 0.47). There was an excessive probability, however,
the increased odds of bladder cancer for participants with
the highest intakes of phosphorus and corresponding high
intake of magnesium (0.55) and low intake of calcium
(0.58) were false-positive ﬁndings. No associations were
below the 0.5 criterion for noteworthiness when we repe-
ated the FPRP estimations using a lower prior probability
of 10%. Calibration of the statistically signiﬁcant p values
obtained for the positive association between calcium
intake and bladder cancer risk and the higher odds asso-
ciated with low magnesium intake and both higher calcium
and phosphorus intakes and low vitamin D together with
high phosphorus intake yielded minimum posterior prob-
abilities of the null hypothesis of no effect (conditional
error probabilities) of 0.79, 0.32, 0.46, and 0.50, respec-
tively, based on a 10% prior probability of the alternative
hypothesis. The minimum posterior probabilities for the
same statistically signiﬁcant ﬁndings were lower for a prior
probability of 25% (data not shown).
No interaction was detected between calcium intake and
sex and smoking characteristics (status, number of ciga-
rettes smoked per day and number of years of cigarette
smoking). However, we did observe an increased risk of
bladder cancer associated with a higher intake of calcium
among older participants compared with the younger age
group (OR: 1.90; 95% CI: 1.08–3.36). Being male and
belonging to the older age group also appeared to increase
the risk of bladder cancer for participants with a higher
intake of phosphorus (OR: 1.93; 95% CI: 1.08–3.44 and
OR: 2.02; 95% CI: 1.05–3.92, respectively). The actual
p values, however, for interaction between these micro-
nutrients and age and sex were not statistically signiﬁcant.
Whereas all FPRP results were noteworthy using a prior
probability of 0.25 only the potential joint effects of
phosphorus and age remained noteworthy at the lower prior
probability of 0.10 (data not shown). A statistically sig-
niﬁcant interaction was observed between vitamin D intake
and the number of cigarettes smoked per day (p-interac-
tion = 0.02), although the reduced odds of bladder cancer
Table 3 Adjusted ORs and 95% CIs for minerals that biologically
interact with each other and the risk of bladder cancer
Calcium
\/[873.6 mg
Phosphorus
\/[1,543 mg
Case Control OR (95% CI)
??116 219 1.30 (0.64–2.63)
?- 14 33 1.35 (0.58–3.18)
-? 21 33 3.02 (1.01–9.02)
-- 47 92 1.00 (reference)
Calcium
\/[873.6 mg
Magnesium
\/[370.5 mg
??101 212 1.24 (0.63–2.43)
?- 29 40 3.45 (1.48–8.04)
a
-? 22 39 2.16 (0.75–6.21)
-- 46 86 1.00 (reference)
Calcium
\/[873.6 mg
Vitamin D
\/[2.1 lg
?? 97 179 1.59 (0.89–2.84)
?- 33 73 1.55 (0.66–3.65)
-? 33 71 0.79 (0.38–1.65)
-- 35 54 1.00 (reference)
Phosphorus
\/[1,543 mg
Magnesium
\/[370.5 mg
??117 228 3.26 (1.10–9.65)
?- 20 24 3.91 (1.45–10.49)
a
-? 6 23 0.64 (0.20–1.99)
-- 55 102 1.00 (reference)
Phosphorus
\/[1,543 mg
Vitamin D
\/[2.1 lg
?? 102 189 1.74 (0.91–3.33)
?- 35 63 4.25 (1.44–12.55)
a
-? 28 61 0.98 (0.45–2.13)
-- 33 64 1.00 (reference)
Adjusted for age, sex, smoking status, number of cigarettes smoked
per day, number of years of cigarette smoking, exposure to occupa-
tional carcinogens (never vs. ever exposure to polycyclic aromatic
hydrocarbons and aromatic amines), and energy intake (kcal/day)
a Remained robust (i.e., statistically signiﬁcant at an alpha = 0.05
with a prior probability of 0.25, for an odds ratio of 1.5 and cut-off
level of 0.5 for false-positive report probability)
474 Cancer Causes Control (2011) 22:469–478
123for heavy smokers ([15 cigarettes/day) with the highest
intake of vitamin D was not statistically signiﬁcant
(OR: 0.61; 95% CI: 0.33–1.12).
Discussion
Main ﬁndings
From our investigations into the effect of dietary minerals
and vitamins on the risk of bladder cancer, we observed a
statistically signiﬁcant positive association with calcium
intake. Although not statistically signiﬁcant, we also
detected an increased odds of bladder cancer associated
with a higher intake of phosphorus. Further analyses
revealed that participants with lower levels of magnesium
and corresponding higher intakes of calcium and phos-
phorus had increased odds of bladder cancer. We also
observed an increased risk of bladder cancer for older
participants with higher intakes of both calcium and
phosphorus. A higher intake of phosphorus also appeared
to increase susceptibility of the disease for men and study
subjects with low vitamin D intake. Furthermore, vitamin
D intake appeared to interact with cigarette smoking
resulting in a possible protective effect among the heaviest
smokers. We did not detect any other potential associa-
tions, trends, or interactions.
Comparisons with existing evidence
According to the second expert report by the World Cancer
Research Fund/American Institute for Cancer Research
[32], the inﬂuence of calcium on cancer risk varies
according to body site. The positive association between
calcium and bladder cancer that we observed is in agree-
ment with the results of a Spanish multi-centre case–
control study [9], although in the Spanish study the effect
disappeared after adjustment for saturated fat intake.
However, our ﬁndings disagree with the results of three
American studies, one large prospective cohort study [6]
and two case–control studies [5, 7], and of a Dutch pro-
spective cohort study [10] that reported no association with
calcium intake.
A complete assessment of the effect of calcium intake
cannot be obtained without taking its metabolic interac-
tions with other food constituents such as phosphorus and
vitamin D into account [15, 33]. For example, high intakes
of phosphorus have been reported to be able to affect the
calcium balance in the body [15]. As for the relationship
with vitamin D, both calcium and phosphorus are consid-
ered to be the ‘‘main dietary regulators’’ of vitamin D
levels in humans [33]. At increased concentrations,
calcium has been reported to reduce levels of vitamin D
[34]. Alternatively, dietary phosphorus has the ability to
inﬂuence vitamin D levels either way based on serum
calcium and phosphorus concentrations [33]. Phosphorus is
available from a wide range of dietary sources such as
dairy products, meat, poultry, ﬁsh, and food additives [15].
Population differences in dietary sources, intake levels, and
mineral balances may explain why an American study [7]
reported a negative association and we conversely detected
a positive association, both of borderline statistical signif-
icance, between dietary phosphorus and bladder cancer.
Measuring vitamin D exposure is difﬁcult because it is
available from two different sources: diet and sunlight
(UV-B radiation) [35]. An ecological study [36] conducted
in the US reported an inverse association between the solar
source of vitamin D, UV-B exposure and bladder cancer.
We only had data regarding dietary intake available and
failed to identify an association between vitamin D intake
overall and bladder cancer risk, which was in agreement
with reports from a large US prospective study [6]. How-
ever, when we evaluated the modifying effects of inter-
related micronutrients we found that participants with high
phosphorus and low vitamin D intakes appeared to be at
increased risk of bladder cancer. We also observed an
interaction between the number of cigarettes smoked per
day and vitamin D intake. Although not statistically sig-
niﬁcant, heavy smokers in the highest group for vitamin D
intake had a reduced odds of bladder cancer. A possible
association between smoking and vitamin D is consistent
with ﬁndings from a Danish cross-sectional study of 510
perimenopausal women [37] that reported decreased serum
vitamin D levels among smokers in the study (50% of
participants).
The potentially protective effect of vitamin D has been
attributed to its role in cell differentiation, proliferation,
and apoptosis [38]. An American study [7] reported a
possible reduced risk of bladder cancer among older par-
ticipants with the highest intake of vitamin D. Many factors
may inﬂuence the nutritional status such as vitamin D
levels of older individuals. These include: living conditions
(e.g., aged care facilities), comorbidities and the regular
use of multiple medications and dietary supplements e.g.,
calcium [8].
Down regulation of the active form of vitamin D (1,25-
dihydroxy vitamin D3) due to high intakes of calcium and
phosphorus may explain the increased risk of bladder
cancer we observed in the older age group [33]. Similarly,
a higher intake of phosphorus may have upset the balance
with vitamin D and contributed to the increased odds of
bladder cancer for the men in our study. A cross-sectional
study [39] investigated the relationship between vitamin D
and other minerals, speciﬁcally calcium and phosphorus,
on bone mass in perimenopausal women. This study [39]
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to phosphorus ratio and serum levels of vitamin D.
Magnesium is another mineral that metabolically inter-
acts with vitamin D, calcium, and phosphorus [39]. In
agreement with the few previous studies that investigated
this mineral [6, 7], we did not detect any association
between bladder cancer and magnesium as such. However,
low levels of magnesium in conjunction with elevated
levels of calcium and phosphorus appeared to exacerbate
the risk of bladder cancer. It has been previously reported
that high intakes of calcium may lead to magnesium deﬁ-
ciency [40]. As a mineral involved in more than 300
enzymatic reactions within the body, magnesium is clearly
an important micronutrient. It should be noted, however,
that in excessively high doses it can be toxic to certain
individuals such as those with advanced renal disease [41].
Other minerals and vitamins have been previously
investigated in this study population [42]. In an earlier
study [42], no statistically signiﬁcant associations were
observed between bladder cancer incidence and intake of
vitamin C, retinol equivalents or vitamin E after adjustment
for age, sex, smoking characteristics, and occupational
exposure to carcinogens. However, a statistically signiﬁ-
cant negative association was reported between serum
levels of selenium and bladder cancer risk [42].
Currently, few epidemiological studies have investi-
gated the effects of the remaining minerals and vitamins for
which we found no association: sodium [5–7], potassium
[6, 7], zinc [17, 18], iron [6, 7, 9], thiamin [5–7], riboﬂavin
[5–7, 19], and copper. Only three of these studies [7, 18,
19] disagreed with our ﬁndings for these micronutrients
and reported inverse associations between bladder cancer
and intake of zinc (borderline statistically signiﬁcant for
total zinc intake) [18], thiamin (older individuals) [7], and
riboﬂavin [19]. To our knowledge, this is the only epide-
miological study that has investigated the association
between copper intake and bladder cancer risk. Consider-
ing the current lack of information and the fact that many
of these minerals and vitamins share common food sources
and may biologically interact mutually and with other
nutrients further investigation of these micronutrients is
warranted [43].
Strengths and limitations of our study
A major strength of our study is the detailed and validated
FFQ [22, 23] used to collect dietary data from our study
population [21]. Although dietary data were collected at
only one point in time (previous 12 month period), the FFQ
has been reported to be an adequate instrument for mea-
suring usual (average) food and nutrient intake for the
purpose of our study [21, 22]. While it is impossible to
discount the possibility that diet may have changed due to
disease status, another case–control study on bladder can-
cer [19] has reported that preclinical disease is unlikely to
cause any major dietary changes. Moreover, given the
general lack of understanding of the role of diet in bladder
cancer etiology, both among experts and in the community,
we are quite conﬁdent that only non-differential mis-
classiﬁcation in dietary intake reporting by cases and
controls may have inﬂuenced the study outcomes. This is
further supported by the fact that there were no statistically
signiﬁcant differences between cases and controls for
major dietary components, energy, and fat intake.
Risk of selection bias is a potential limitation associated
with the case–control design, however, as previously
reported [44] the study participants were demographically
fair representatives of the general population. Although
there were a higher proportion of high risk groups of
bladder cancer among the cases compared with the con-
trols. These included older participants, men, and heavy
smokers who were also the groups of individuals with
imbalances in dietary intake of calcium, phosphorus, and
vitamin D.
The relatively small sample size is another potential
limitation of this study. As a consequence of low statistical
power, small effects of nutrient intakes as both main and
joint effects may go undetected. Additionally, the lower
proportion of low risk groups (e.g., younger participants,
women and non-smokers) among the cases further limits
the power of the study to show potential associations for
these low risk groups.
Another potential weakness associated with this type of
study design is the issue of multiple testing. We attempted
to address this by performing additional analyses such as
the FPRP test and calibration of p values to evaluate
potential false-positive ﬁndings [27, 29]. Of these two
methods, only the calibrated p values provided some evi-
dence, although weak, for the modifying effects of inter-
related micronutrients on bladder cancer risk at the lower
prior probability of 10%. While these calculations can
provide additional support for potential effects they are
limited by the difﬁculty in determining an appropriate prior
probability [27]. Cross-validation with other studies was
another means by which we attempted to assess statistically
signiﬁcant ﬁndings obtained from multiple investigations.
Conclusion
We found a positive association between calcium intake
and bladder cancer. There was some evidence of an
interaction between intakes of magnesium and both phos-
phorus and calcium and phosphorus and vitamin D intake.
Sub-optimal levels and balances between the related
micronutrients calcium, phosphorus, magnesium and
476 Cancer Causes Control (2011) 22:469–478
123vitamin D may inﬂuence bladder cancer risk. Individuals
most affected by these micronutrient imbalances appeared
to be those generally considered being at highest risk of
bladder cancer: older participants, males, and heavy
smokers.
Our results need to be conﬁrmed by other studies, and
further investigation is clearly required to determine opti-
mal intakes and balances between these and other inter-
related nutrients.
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